| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Articles |
Departments of Pediatrics (M.L.S., D.L.M., R.H.H.), Medicine (D.L., K-Y.N.), and Neuroscience, (X-Y.H., R.H.H.), University of California, San Diego, California 92093; and Department of Molecular and Medical Genetics, Oregon Health Sciences University, (N.G.K.), Portland, Oregon 97201
Address all correspondence and requests for reprints to: Richard H. Haas, Department of Neurosciences, Division of Pediatric Neurology, University of California, San Diego, 9500 Gilman Drive, Department 0935, La Jolla, California 92093-0935.
A 6-yr-old boy presented with muscle weakness, lactic acidemia, and insulin-dependent diabetes mellitus (IDDM). Using PCR and restriction enzyme analysis, he was found to have the classical A3243G mitochondrial DNA (mtDNA) mutation frequently associated with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). The mutation was confirmed by sequencing muscle mtDNA. The mutation in mtDNA from muscle, lymphoblasts, and blood was clearly demonstrable by standard methods using ethidium bromide staining. His mother also had IDDM, but no A3243G mutation could be detected in her blood or transformed lymphoblasts using the same PCR technique. When PCR was carried out in the presence of [32P]deoxycytidine triphosphate, subsequent autoradiography detected the presence of the mutation at low levels in mtDNA from the mothers lymphoblasts and blood. Study of the mothers muscle showed a mitochondrial myopathy, despite the fact that she was asymptomatic. We emphasize that the increased sensitivity of radiolabeled PCR may be necessary to detect small percentages of heteroplasmic A3243G mtDNA mutation in blood from diabetic subjects. Otherwise the incidence of mtDNA mutations in both IDDM and non-insulin dependent diabetes may be underestimated.
This article has been cited by other articles:
![]() |
Y. Jiang, T. A. Hall, S. A. Hofstadler, and R. K. Naviaux Mitochondrial DNA Mutation Detection by Electrospray Mass Spectrometry Clin. Chem., February 1, 2007; 53(2): 195 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Singh, S. Ellard, A. Hattersley, and L. W. Harries Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation J. Mol. Diagn., May 1, 2006; 8(2): 225 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohkubo, A. Yamano, M. Nagashima, Y. Mori, K. Anzai, Y. Akehi, R. Nomiyama, T. Asano, A. Urae, and J. Ono Mitochondrial Gene Mutations in the tRNALeu(UUR) Region and Diabetes: Prevalence and Clinical Phenotypes in Japan Clin. Chem., September 1, 2001; 47(9): 1641 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guttman, H.-G. Gao, and R. Haas Rapid Analysis of Mitochondrial DNA Heteroplasmy in Diabetes by Gel-Microchip Electrophoresis Clin. Chem., August 1, 2001; 47(8): 1469 - 1472. [Full Text] [PDF] |
||||
![]() |
W. D. Graf, J. Marin-Garcia, H.G. Gao, S. Pizzo, R. K. Naviaux, D. Markusic, B. A. Barshop, E. Courchesne, and R. H. Haas Autism Associated With the Mitochondrial DNA G8363A Transfer RNALys Mutation J Child Neurol, June 1, 2000; 15(6): 357 - 361. [Abstract] [PDF] |
||||
![]() |
A. Pugliese, E. Kawasaki, M. Zeller, L. Yu, S. Babu, M. Solimena, C. T. Moraes, M. Pietropaolo, R. P. Friday, M. Trucco, et al. Sequence Analysis of the Diabetes-Protective Human Leukocyte Antigen-DQB10602 Allele in Unaffected, Islet Cell Antibody-Positive First Degree Relatives and in Rare Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1722 - 1728. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |